We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$190M
AUM Growth
+$27.1M
Cap. Flow
+$12.9M
Cap. Flow %
6.79%
Top 10 Hldgs %
52.33%
Holding
32
New
7
Increased
10
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$9.53M
2
WMT icon
Walmart Inc
WMT
+$8.17M
3
DE icon
Deere & Co
DE
+$7.82M
4
ENPH icon
Enphase Energy
ENPH
+$7.26M
5
NVO
Novo Nordisk
NVO
+$1.54M

Sector Composition

Rank Sector Weight
1 Financials 26.48%
2 Healthcare 20.76%
3 Industrials 20.4%
4 Technology 11.42%
5 Consumer Discretionary 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$123B
$11.3M 5.96%
39,155
COR icon
2
Cencora
COR
$62B
$10.6M 5.57%
63,879
-2,040
-3% -$322K
AZO icon
3
AutoZone
AZO
$51.3B
$10.4M 5.47%
4,192
-114
-3% -$276K
AMP icon
4
Ameriprise Financial
AMP
$47.8B
$10M 5.28%
32,245
+2,275
+8% +$694K
SCHW
5
Charles Schwab
SCHW
$182B
$10M 5.26%
120,122
+16,672
+16% +$1.29M
GS icon
6
Goldman Sachs
GS
$289B
$9.91M 5.21%
28,853
+724
+3% +$252K
AJG icon
7
Arthur J. Gallagher & Co
AJG
$69.1B
$9.7M 5.1%
51,443
-932
-2% -$174K
IWM icon
8
iShares Russell 2000 ETF
IWM
$79.1B
$9.35M 4.92%
+53,607
New +$9.53M
MS icon
9
Morgan Stanley
MS
$319B
$9.31M 4.9%
109,548
+5,889
+6% +$502K
LNG icon
10
Cheniere Energy
LNG
$54.2B
$8.84M 4.65%
58,972
-859
-1% -$144K
UNH icon
11
UnitedHealth
UNH
$382B
$8.54M 4.5%
16,114
-3,436
-18% -$1.82M
NOC icon
12
Northrop Grumman
NOC
$76B
$8.26M 4.35%
15,135
-295
-2% -$154K
DE icon
13
Deere & Co
DE
$165B
$8.25M 4.34%
+19,247
New +$7.82M
WMT icon
14
Walmart Inc
WMT
$909B
$8.14M 4.28%
+172,137
New +$8.17M
RTX icon
15
RTX Corp
RTX
$290B
$8.07M 4.25%
79,958
+462
+0.6% +$43.5K
JBHT icon
16
JB Hunt Transport Services
JBHT
$25.9B
$7.51M 3.95%
43,083
+433
+1% +$75.6K
TMO icon
17
Thermo Fisher Scientific
TMO
$214B
$7.22M 3.8%
13,112
+162
+1% +$85.8K
APH icon
18
Amphenol
APH
$185B
$7.07M 3.72%
185,618
+2,318
+1% +$87.7K
ODFL icon
19
Old Dominion Freight Line
ODFL
$46.3B
$6.67M 3.51%
47,008
+588
+1% +$83.5K
ENPH icon
20
Enphase Energy
ENPH
$4.63B
$6.62M 3.48%
+24,969
New +$7.26M
AAPL icon
21
Apple
AAPL
$4.97T
$6.02M 3.17%
46,365
-311
-0.7% -$44.4K
INDA icon
22
iShares MSCI India ETF
INDA
$6.81B
$1.98M 1.04%
47,325
+12,675
+37% +$537K
NVO
23
Novo Nordisk
NVO
$228B
$1.77M 0.93%
+26,200
New +$1.54M
IBN icon
24
ICICI Bank
IBN
$107B
$1.36M 0.72%
+62,150
New +$1.38M
FN icon
25
Fabrinet
FN
$14.9B
$1.21M 0.63%
+9,410
New +$1.12M

Similar funds

Marvin & Palmer Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Marvin & Palmer Associates held 32 positions worth $190M, up 17% from $163M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Marvin & Palmer Associates deployed $12.9M of net new capital in Q4 2022, opening 7 new positions and adding to 10 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 53,607 shares worth $9.35M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.82M trimmed.

  • Marvin & Palmer Associates's largest Q4 2022 buy was iShares Russell 2000 ETF: 53,607 shares worth $9.35M.
  • Marvin & Palmer Associates added most to Charles Schwab in Q4 2022, an estimated $1.29M increase.
  • Marvin & Palmer Associates's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $1.82M.
  • Marvin & Palmer Associates fully exited Palo Alto Networks in Q4 2022, selling an estimated $7.81M.
  • Marvin & Palmer Associates's ten largest holdings make up 52% of its $190M portfolio in Q4 2022.
  • Marvin & Palmer Associates opened 7 new positions and closed 5 in Q4 2022.
  • Marvin & Palmer Associates's portfolio value rose 17% quarter-over-quarter to $190M.

Based on Marvin & Palmer Associates's 13F filing for Q4 2022, filed 14 Feb 2023.